Human milk oligosaccharides (HMOs) serve as prebiotics, fostering the growth and function of beneficial bacteria in an infant's gut, with a special emphasis on Bifidobacteria. This plays a pivotal role in establishing and sustaining a healthy gut microbiota in infants. Promoting Bifidobacteria is crucial for digestive processes, nutrient absorption, and gastrointestinal well-being. HMOs contribute to developing a balanced and diverse microbial community in the infant's gut, supporting long-term health outcomes. This prebiotic function underscores the unique importance of HMOs in human breast milk, emphasizing their role beyond basic nutrition in ensuring the well-being of the developing digestive system.
According to Data Bridge Market Research analyses, the Global Human Milk Oligosaccharides (HMOs) Market was valued at USD 22.3 million in 2021 and is expected to reach the value of USD 109.51 million by 2029, at a CAGR of 22.01% during the forecast period of 2022 to 2029.
"Rise in demand for dietary supplements boosts the market growth"
The rising demand for dietary supplements can be attributed to the increasing recognition of human milk oligosaccharides (HMOs) as a significant market driver. HMOs, naturally occurring compounds in human breast milk, have gained attention for their potential health benefits, including supporting the development of a healthy gut microbiome and immune system. As awareness grows regarding the importance of early nutrition and its impact on long-term health, consumers are seeking products that incorporate HMOs as key ingredients. This surge in demand for HMOs in dietary supplements reflects a broader trend towards personalized and functional nutrition, driving the market towards innovative and science-backed solutions to enhance well-being.
What restraints the growth of the global human milk oligosaccharides market?
“Lack of advanced technology hampers the market growth”
The human milk oligosaccharides (HMOs) market faces a significant constraint due to the lack of advanced technology for large-scale production. The intricate nature of HMO synthesis requires sophisticated and precise manufacturing processes, which are currently limited in terms of scalability. This technological bottleneck hampers the ability to meet the growing demand for HMOs efficiently and economically, restricting the market's expansion.
Segmentation: Global Human Milk Oligosaccharides Market
The global human milk oligosaccharides market is segmented on the basis of type, product, application, and distribution channel.
- On the basis of type, the global human milk oligosaccharides market is segmented into 2’FL, 3’FL, 3’SL, and 6’SL
- On the basis of product, the global human milk oligosaccharides market is segmented into fucosyllactose, LNT and LNnT, and sialyllactose
- On the basis of application, the global human milk oligosaccharides market is segmented into infant formula, functional food and beverages, food supplements, health ingredients for human and animal, and others
- On the basis of distribution channel, the global human milk oligosaccharides market is segmented into hypermarkets and supermarkets, drug store or pharmacy, mass merchandiser, departmental stores, mono-brand stores, specialty stores, and online sales channel
Regional Insights: Europe dominates the Global Human Milk Oligosaccharides Market
In Europe, Germany dominates the human milk oligosaccharides (HMOs) market due to a rising health consciousness among Europe consumers. As awareness of the health benefits associated with HMOs increases, Germany's market presence is expected to play a pivotal role in shaping and driving the Europe market for these beneficial compounds.
The Asia-Pacific is expected to experience rapid growth in the upcoming forecast period, outpacing other regions. Factors such as increasing economic development, rising population, and a growing awareness of market trends contribute to this accelerated expansion. The region's dynamic business landscape and a surge in consumer demand further propel its position as the fastest-growing market, offering lucrative opportunities for businesses and investors.
To know more about the study, visit: https://www.databridgemarketresearch.com/reports/global-human-milk-oligosaccharides-market
Recent Developments in Global Human Milk Oligosaccharides Market
- In February 2019, Jennewein Biotechnologie GmbH, a German functional sugars manufacturer, collaborated with China-based dairy products manufacturer Yili.Com Inc. for research on infant microbiome and human milk oligosaccharides. This strategic alliance aimed to innovate and develop an HMO-based infant formula tailored for Chinese consumers. As market competition intensifies, similar developments and strategies are anticipated to unfold throughout the forecast period
The Prominent Key Players Operating in the Global Human Milk Oligosaccharides Market Include:
- ZuChem Inc. (U.S)
- Elicityl SA (France)
- Jennewein Biotechnologie GmbH (Germany)
- Royal FrieslandCampina NV (Netherlands)
- BASF SE (Germany)
- Gnubiotics (Switzerland)
- DuPont Nutrition & Health (Denmark)
- Inbiose NV (Belgium)
- Glycom A/S (Denmark)
- Glycosyn LLC (U.S.)
Above are the key players covered in the report, to know about more and exhaustive list of global human milk oligosaccharides market companies contact, https://www.databridgemarketresearch.com/contact
Research Methodology: Global Human Milk Oligosaccharides Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, global vs Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.
